Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy1
Outperform0
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The one analyst offering a 12 month price target expects Merck KGaA (ADR) share price to rise to 42.20 in the next year from the last price of 29.08.
High45.1%42.20
Med45.1%42.20
Low45.1%42.20

Dividends

Historical dividend information is not available for Merck KGaA.
Div growth (TTM)--
More ▼

Earnings history & estimates in USD

On Nov 14, 2024, Merck KGaA (ADR) reported 3rd quarter 2024 earnings of 0.46 per share.
The next earnings announcement is expected on Mar 06, 2025.
Average growth rate+0.96%
Merck KGaA (ADR) reported annual 2023 earnings of 1.84 per share on Mar 07, 2024.
Average growth rate-1.74%
More ▼

Revenue history & estimates in USD

Merck KGaA (ADR) had 3rd quarter 2024 revenues of 5.27bn. This missed the 5.77bn estimate of the one analyst following the company. This was 7.27% below the prior year's 3rd quarter results.
Average growth rate-1.53%
Merck KGaA (ADR) had revenues for the full year 2023 of 22.70bn. This was 2.81% below the prior year's results.
Average growth rate+6.14%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.